retatrutide type 2 diabetes trial results 2024 Lilly's triple agonist achieves 16.8% weight loss in phase 3 This data from Phase 3

Id have an animal sanctuary

Commentary establishing the multimodal treatment recommendation framework

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help contextualize your individual GLP-1 tolerability patterns, including predispositions to gastrointestinal side effects

Its become the most extraordinary class of drugs, I think in medical history, having been a student of various, I mean obviously statins have been a major contribution, but this seems to have transcended that already

We appreciate you being a member

MELK/MPK38 in cancer: from mechanistic aspects to therapeutic strategies